{"id": "j7cyANIAxV", "round": 0, "round_best": "Develop a temporal-based split methodology for training and testing datasets in drug-target binding affinity prediction where data is divided based on the chronological order of drug discovery or reporting. This approach would simulate a more realistic scenario where future predictions are made on drug targets that do not share temporal data with the training set, better mimicking real-world situations where entirely new drug molecules are tested. Additionally, incorporate temporal features directly into the model to leverage the progression and evolution in drug design and target characteristics over time, potentially revealing more robust and generalizable insights about drug-target interactions.", "round_best_score": 0.55, "best_so_far": "Develop a temporal-based split methodology for training and testing datasets in drug-target binding affinity prediction where data is divided based on the chronological order of drug discovery or reporting. This approach would simulate a more realistic scenario where future predictions are made on drug targets that do not share temporal data with the training set, better mimicking real-world situations where entirely new drug molecules are tested. Additionally, incorporate temporal features directly into the model to leverage the progression and evolution in drug design and target characteristics over time, potentially revealing more robust and generalizable insights about drug-target interactions.", "best_score_so_far": 0.55, "#explored_so_far": 0, "#cands_this_round": 0}
{"id": "j7cyANIAxV", "round": 1, "round_best": "Implement a cross-validation scheme that uses stratified splits based on molecular properties or target classes. This method would ensure that each fold of validation contains a representative mix of drug-target pairs, differing significantly from the training folds in terms of chemical and biological properties, thus providing a more stringent test of model generalizability.", "round_best_score": 0.75, "best_so_far": "Implement a cross-validation scheme that uses stratified splits based on molecular properties or target classes. This method would ensure that each fold of validation contains a representative mix of drug-target pairs, differing significantly from the training folds in terms of chemical and biological properties, thus providing a more stringent test of model generalizability.", "best_score_so_far": 0.75, "#explored_so_far": 8, "#cands_this_round": 8}
{"id": "j7cyANIAxV", "round": 2, "round_best": "Utilize a cluster-based validation approach where drug-target pairs are grouped based on clustering algorithms that consider multiple molecular and biological features, and ensuring minimal overlap between clusters in training and test sets. This can help in assessing the model's performance across diverse chemical spaces.", "round_best_score": 0.72, "best_so_far": "Implement a cross-validation scheme that uses stratified splits based on molecular properties or target classes. This method would ensure that each fold of validation contains a representative mix of drug-target pairs, differing significantly from the training folds in terms of chemical and biological properties, thus providing a more stringent test of model generalizability.", "best_score_so_far": 0.75, "#explored_so_far": 12, "#cands_this_round": 4}
{"id": "j7cyANIAxV", "round": 3, "round_best": "Utilize adversarial validation techniques to identify and segregate drug-target pairs that are most dissimilar from the training dataset, creating a challenging test set that rigorously assesses model robustness and generalizability.", "round_best_score": 0.75, "best_so_far": "Implement a cross-validation scheme that uses stratified splits based on molecular properties or target classes. This method would ensure that each fold of validation contains a representative mix of drug-target pairs, differing significantly from the training folds in terms of chemical and biological properties, thus providing a more stringent test of model generalizability.", "best_score_so_far": 0.75, "#explored_so_far": 17, "#cands_this_round": 5}
{"id": "j7cyANIAxV", "round": 4, "round_best": "Employ a leave-one-out cross-validation strategy specifically focusing on unique target classes or rare molecular scaffolds. This method would ensure that the model's ability to generalize across diverse biological mechanisms and chemical structures is rigorously tested.", "round_best_score": 0.68, "best_so_far": "Implement a cross-validation scheme that uses stratified splits based on molecular properties or target classes. This method would ensure that each fold of validation contains a representative mix of drug-target pairs, differing significantly from the training folds in terms of chemical and biological properties, thus providing a more stringent test of model generalizability.", "best_score_so_far": 0.75, "#explored_so_far": 23, "#cands_this_round": 6}
{"id": "j7cyANIAxV", "round": 5, "round_best": "Employ a cluster-based validation technique where drug-target pairs are grouped by structural similarity, and clusters are split between training and testing sets. This ensures that the test set includes drug-target pairs that are structurally distinct from those in the training set, presenting a more challenging and realistic evaluation.", "round_best_score": 0.68, "best_so_far": "Implement a cross-validation scheme that uses stratified splits based on molecular properties or target classes. This method would ensure that each fold of validation contains a representative mix of drug-target pairs, differing significantly from the training folds in terms of chemical and biological properties, thus providing a more stringent test of model generalizability.", "best_score_so_far": 0.75, "#explored_so_far": 27, "#cands_this_round": 4}
{"id": "j7cyANIAxV", "round": 6, "round_best": "Develop a hybrid evaluation scheme that combines randomized and stratified splits, where initial testing uses randomized splits for baseline performance assessment, followed by stratified splits for a more rigorous evaluation. This two-tier approach allows for a comprehensive understanding of model effectiveness across varying levels of similarity.", "round_best_score": 0.75, "best_so_far": "Implement a cross-validation scheme that uses stratified splits based on molecular properties or target classes. This method would ensure that each fold of validation contains a representative mix of drug-target pairs, differing significantly from the training folds in terms of chemical and biological properties, thus providing a more stringent test of model generalizability.", "best_score_so_far": 0.75, "#explored_so_far": 31, "#cands_this_round": 4}
{"id": "j7cyANIAxV", "round": 7, "round_best": "Develop a tiered evaluation framework where initial model assessments use traditional random splits, followed by progressively more challenging splits based on increasing levels of dissimilarity in molecular properties or target classes, to better understand model performance across a spectrum of similarity.", "round_best_score": 0.78, "best_so_far": "Develop a tiered evaluation framework where initial model assessments use traditional random splits, followed by progressively more challenging splits based on increasing levels of dissimilarity in molecular properties or target classes, to better understand model performance across a spectrum of similarity.", "best_score_so_far": 0.78, "#explored_so_far": 35, "#cands_this_round": 4}
{"id": "j7cyANIAxV", "round": 8, "round_best": "Implement a cross-validation scheme where each fold is specifically designed to contain increasingly dissimilar drug-target pairs, thus providing a more rigorous assessment of the model's robustness and generalization capabilities.", "round_best_score": 0.75, "best_so_far": "Develop a tiered evaluation framework where initial model assessments use traditional random splits, followed by progressively more challenging splits based on increasing levels of dissimilarity in molecular properties or target classes, to better understand model performance across a spectrum of similarity.", "best_score_so_far": 0.78, "#explored_so_far": 41, "#cands_this_round": 6}
{"id": "j7cyANIAxV", "round": 9, "round_best": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "round_best_score": 0.85, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 48, "#cands_this_round": 7}
{"id": "j7cyANIAxV", "round": 10, "round_best": "Apply a reinforcement learning approach to optimize the selection of drug-target pairs for the test set, aiming to maximize model exposure to both chemically similar and dissimilar compounds, thereby improving the accuracy and reliability of affinity predictions.", "round_best_score": 0.82, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 55, "#cands_this_round": 7}
{"id": "j7cyANIAxV", "round": 11, "round_best": "Develop a stratified cross-validation framework where drug-target pairs are grouped based on structural and functional similarities, and each fold contains a representative mix of each group, promoting a comprehensive evaluation across diverse molecular interactions.", "round_best_score": 0.78, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 59, "#cands_this_round": 4}
{"id": "j7cyANIAxV", "round": 12, "round_best": "Apply a multi-objective optimization strategy to the cross-validation design, balancing the need for dissimilarity with other relevant factors such as the chemical diversity of the drugs and the genetic diversity of the targets.", "round_best_score": 0.78, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 64, "#cands_this_round": 5}
{"id": "j7cyANIAxV", "round": 13, "round_best": "Apply adversarial training methods to generate synthetic drug-target pairs that are maximally dissimilar from the training set, thereby training the model to maintain performance under diverse conditions.", "round_best_score": 0.55, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 67, "#cands_this_round": 3}
{"id": "j7cyANIAxV", "round": 14, "round_best": "Introduce a tiered validation approach where the dataset is stratified based on the structural and chemical diversity of drug-target pairs, ensuring that each validation fold contains a representative spectrum of similarity and complexity.", "round_best_score": 0.82, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 71, "#cands_this_round": 4}
{"id": "j7cyANIAxV", "round": 15, "round_best": "Develop a novel evaluation metric that adjusts traditional performance scores by a factor derived from the similarity between training and test sets, providing a more accurate reflection of a model's ability to handle diverse drug-target interactions.", "round_best_score": 0.68, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 73, "#cands_this_round": 2}
{"id": "j7cyANIAxV", "round": 16, "round_best": "Introduce a tiered evaluation framework that categorizes test samples based on their structural and chemical similarity to training samples, then assesses model performance separately within each category, allowing for a nuanced understanding of model robustness across different levels of similarity.", "round_best_score": 0.78, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 76, "#cands_this_round": 3}
{"id": "j7cyANIAxV", "round": 17, "round_best": "Incorporate a domain adaptation technique in the cross-validation process, where models are initially trained on a source domain (similar drug-target pairs) and progressively adapted to a target domain (dissimilar pairs) within each fold.", "round_best_score": 0.65, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 78, "#cands_this_round": 2}
{"id": "j7cyANIAxV", "round": 18, "round_best": "Introduce an adaptive sampling method where the degree of dissimilarity between the training and validation sets is incrementally increased in each fold of the cross-validation, allowing for a gradual assessment of model robustness across a spectrum of similarity scenarios.", "round_best_score": 0.82, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 80, "#cands_this_round": 2}
{"id": "j7cyANIAxV", "round": 21, "round_best": "Develop a hybrid evaluation approach combining cross-validation with adversarial testing, where models face both standard cross-validation folds and additional adversarially generated folds that maximize dissimilarity to training data.", "round_best_score": 0.78, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 82, "#cands_this_round": 2}
{"id": "j7cyANIAxV", "round": 22, "round_best": "Incorporate an adversarial validation setup, where the test sets are specifically designed to include the most challenging drug-target pairs based on historical model performance, thus continuously pushing the boundaries of model robustness.", "round_best_score": 0.72, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 86, "#cands_this_round": 4}
{"id": "j7cyANIAxV", "round": 23, "round_best": "Apply a multi-tier cross-validation strategy that not only varies the similarity of drug-target pairs in each fold but also integrates different types of molecular descriptors and binding affinity measurements, providing a comprehensive evaluation across multiple dimensions.", "round_best_score": 0.72, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 87, "#cands_this_round": 1}
{"id": "j7cyANIAxV", "round": 24, "round_best": "Apply a tiered validation process where initial model assessments use a conventional randomized split, followed by a more challenging validation stage that uses a custom-designed dissimilarity-based split, providing a phased assessment of model robustness.", "round_best_score": 0.72, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 90, "#cands_this_round": 3}
{"id": "j7cyANIAxV", "round": 25, "round_best": "Enhance the cross-validation setup with an iterative feedback loop where after each fold, the model's performance on dissimilar pairs is analyzed and used to adjust the composition of subsequent folds, continuously optimizing the diversity of test scenarios.", "round_best_score": 0.72, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 92, "#cands_this_round": 2}
{"id": "j7cyANIAxV", "round": 26, "round_best": "Implement a dynamic sampling cross-validation method where the dissimilarity threshold is adjusted based on the model's performance in previous folds, allowing for adaptive learning and more nuanced performance evaluation.", "round_best_score": 0.78, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 94, "#cands_this_round": 2}
{"id": "j7cyANIAxV", "round": 27, "round_best": "Implement an ensemble learning approach where multiple models are trained on varying degrees of dissimilarity within the data, and their predictions are combined to achieve a more reliable estimation of binding affinity across diverse chemical entities.", "round_best_score": 0.72, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 96, "#cands_this_round": 2}
{"id": "j7cyANIAxV", "round": 28, "round_best": "Utilize graph-based techniques to map the chemical space of drugs and targets, using these representations to guide the selection of test sets that are structurally diverse from the training sets, aiming to challenge the model's extrapolation capabilities.", "round_best_score": 0.68, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 97, "#cands_this_round": 1}
{"id": "j7cyANIAxV", "round": 29, "round_best": "Employ a dynamic re-weighting system in the training process that increases the importance of dissimilar drug-target pairs over iterations, thus encouraging the model to better learn from and predict such challenging pairs.", "round_best_score": 0.45, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 98, "#cands_this_round": 1}
{"id": "j7cyANIAxV", "round": 30, "round_best": "Employ a tiered validation system where initial model assessments use similar drug-target pairs and subsequent layers of validation use increasingly dissimilar pairs, providing a phased approach to evaluating model robustness.", "round_best_score": 0.75, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 100, "#cands_this_round": 2}
{"id": "j7cyANIAxV", "round": 31, "round_best": "Introduce an adaptive testing protocol where the degree of dissimilarity between training and test sets is incrementally increased, allowing researchers to systematically evaluate the robustness of their models against progressively more challenging datasets.", "round_best_score": 0.82, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 102, "#cands_this_round": 2}
{"id": "j7cyANIAxV", "round": 32, "round_best": "Employ an adversarial validation approach, where the distribution of the test set is intentionally crafted to be dissimilar from the training set, thus mimicking worst-case scenarios and testing the model's robustness under extreme conditions.", "round_best_score": 0.75, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 105, "#cands_this_round": 3}
{"id": "j7cyANIAxV", "round": 33, "round_best": "Develop an adaptive testing protocol where the degree of dissimilarity between training and test sets is incrementally increased, allowing researchers to systematically assess the model's performance under progressively challenging conditions.", "round_best_score": 0.82, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 108, "#cands_this_round": 3}
{"id": "j7cyANIAxV", "round": 34, "round_best": "Employ graph-based techniques to represent drug-target interactions, using node and edge features to implicitly capture and control for the similarity in the cross-validation folds, enhancing the model's ability to handle diverse molecular structures.", "round_best_score": 0.55, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 109, "#cands_this_round": 1}
{"id": "j7cyANIAxV", "round": 35, "round_best": "Incorporate a graph-based representation learning framework where nodes represent drugs and targets, and edges represent known affinities, with test sets designed to include novel, minimally connected components to test extrapolation capabilities.", "round_best_score": 0.55, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 110, "#cands_this_round": 1}
{"id": "j7cyANIAxV", "round": 36, "round_best": "Develop a meta-learning scheme where the model is trained on a variety of drug-target datasets with known dissimilarity issues, allowing it to learn how to quickly adapt to new, unseen datasets that may have different characteristics.", "round_best_score": 0.55, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 113, "#cands_this_round": 3}
{"id": "j7cyANIAxV", "round": 37, "round_best": "Develop a hybrid evaluation protocol combining randomized and stratified splits, where initial model assessments use randomized data and final evaluations are conducted on carefully curated stratified datasets to capture performance nuances.", "round_best_score": 0.72, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 116, "#cands_this_round": 3}
{"id": "j7cyANIAxV", "round": 38, "round_best": "Adopt a scaffold-based splitting method for the test sets, where drug molecules are grouped by their core structures, ensuring that the test set contains structurally diverse compounds compared to the training set, which may better represent real-world scenarios.", "round_best_score": 0.65, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 117, "#cands_this_round": 1}
{"id": "j7cyANIAxV", "round": 40, "round_best": "Introduce an adversarial validation step where the model's ability to differentiate between training and artificially generated dissimilar test samples is evaluated, enhancing the robustness of the model against diverse molecular structures.", "round_best_score": 0.68, "best_so_far": "Implement a cross-validation scheme where each fold is designed with a controlled degree of dissimilarity, ensuring that every model is validated against both similar and dissimilar drug-target pairs, thus providing a more robust measure of model performance.", "best_score_so_far": 0.85, "#explored_so_far": 118, "#cands_this_round": 1}
